As of 2025-06-23, the Intrinsic Value of Oric Pharmaceuticals Inc (ORIC) is -7.57 USD. This ORIC valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.31 USD, the upside of Oric Pharmaceuticals Inc is -181.36%.
Based on its market price of 9.31 USD and our intrinsic valuation, Oric Pharmaceuticals Inc (ORIC) is overvalued by 181.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.57 - -7.57 | -7.57 | -181.36% |
| P/E | (19.24) - (39.39) | (29.13) | -412.8% |
| DDM - Stable | (10.68) - (28.90) | (19.79) | -312.5% |
| DDM - Multi | (0.16) - (0.32) | (0.21) | -102.3% |
| Market Cap (mil) | 816.45 |
| Beta | 1.61 |
| Outstanding shares (mil) | 87.70 |
| Enterprise Value (mil) | 767.11 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.32% |
| Cost of Debt | 5.00% |
| WACC | 7.50% |